GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeOne Medicines Ltd (SHSE:688235) » Definitions » Net Interest Margin (Bank Only) %

BeOne Medicines (SHSE:688235) Net Interest Margin (Bank Only) %


View and export this data going back to 2021. Start your Free Trial

What is BeOne Medicines Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.


BeOne Medicines Business Description

Industry
Address
c/o BeOne Medicines I GmbH, Aeschengraben 27, 21st Floor, Basel, CHE, 4051
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.